Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for Cardioprotection in Diabetic Cardiac Surgery
NCT02407626Terminated
- Sponsor
- Stadtspital Zürich Triemli
- Start
- Sep 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane in Myocardial ischemia (MI) (2 arms), sponsored by Stadtspital Zürich Triemli. Primary endpoint: N-terminal pro-brain natriuretic peptide. Started Sep 2015; status: terminated.
02
Drugs
sevoflurane
03
Conditions
Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT02407626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407626.